<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2022.1012018</article-id><article-id pub-id-type="publisher-id">JBM-122034</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Socio-Demographic Determinant of Yellow Fever Patient: A Retrospective Study (2020), Federal Medical Center, Asaba
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ngozi</surname><given-names>Esther Ezunu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Joy</surname><given-names>Ifeyinwa Egeonu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ajiri</surname><given-names>Henry Osihro</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Uyi-Oghosa</surname><given-names>Onyemushani</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdulkarim</surname><given-names>Said</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Omole</surname><given-names>Clementina Oyakhire</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Onyema</surname><given-names>Edith Wayemeru</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chidera</surname><given-names>Olivia Okey-Ezufo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chikadibia</surname><given-names>Eze-Otulaka</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Faith</surname><given-names>Inegbejie</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Clever</surname><given-names>Ajiri Oghale</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diana</surname><given-names>Chinenye Ofomata</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Grace</surname><given-names>Nnenna Onubogu</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Orhomuromo</surname><given-names>Paul Okpomo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Eguolo</surname><given-names>Unique Okorhi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Onobhase</surname><given-names>Theresa Agbele</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Anastacia</surname><given-names>Okwudili Ojimba</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Adesuwa</surname><given-names>Queen Aigbokhaode</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Francis</surname><given-names>Chinedu Ugoeze</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Victor</surname><given-names>Azubike Osiatuma</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Emmanuel</surname><given-names>Okechukwu Ezunu</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Obianuju</surname><given-names>Nkemjika Jisieike</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Efe</surname><given-names>Erhinyaye Omoyibo</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Department of Internal Medicine, Federal Medical Centre, Asaba, Nigeria</addr-line></aff><aff id="aff1"><addr-line>Department of Nursing, Federal Medical Centre, Asaba, Nigeria</addr-line></aff><aff id="aff5"><addr-line>Department of Health Information Management, Federal Medical Centre, Asaba, Nigeria</addr-line></aff><aff id="aff2"><addr-line>CCDRC Federal Medical Centre, Asaba, Nigeria</addr-line></aff><aff id="aff4"><addr-line>Department of Radiology, Federal Medical Centre, Asaba, Nigeria</addr-line></aff><aff id="aff6"><addr-line>Department of Pediatrics, Federal Medical Centre, Asaba, Nigeria</addr-line></aff><pub-date pub-type="epub"><day>02</day><month>12</month><year>2022</year></pub-date><volume>10</volume><issue>12</issue><fpage>225</fpage><lpage>238</lpage><history><date date-type="received"><day>24,</day>	<month>October</month>	<year>2022</year></date><date date-type="rev-recd"><day>25,</day>	<month>December</month>	<year>2022</year>	</date><date date-type="accepted"><day>28,</day>	<month>December</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Yellow fever is transmitted primarily to humans and non-human primates through the bite of an infected female mosquito Aedes Spp. It is prevented mainly by vaccination. 
  Method: This retrospective observational study at the Center for Communicable Disease Control and Research (CCDCR) Federal Medical Center Asaba (F.M.C) was conducted on all patients diagnosed and managed with yellow fever in the year 2020. We studied a total number of 57 patients’ case files seen within the period. A chi-square test was done to test the null and alternative hypotheses. 
  Result: About 48 (84.2%) males and female 9 (15.8%) females were mostly affected and gender was significant with a chi-squared value of 26.6 and p-value of 0.00. 
  Conclusion: To eradicate this virus, vaccination and health promotions should be encouraged by the health care workers supported by the government. This is to ensure that a greater proportion of the affected community can be immunized.
 
</p></abstract><kwd-group><kwd>Yellow Fever</kwd><kwd> Socio-Demograpic</kwd><kwd> Determinants</kwd><kwd> Asaba</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>2. Justifications of Study</title><p>The yellow fever outbreak is a serious condition of public health concern. The majority of the patients with the disease present late as yellow fever has signs and symptoms similar to some known diseases like malaria, and Lassa fever. The case fatality rate for hospitalized patients was approximately 40% (WHO 2019) which is high; the severity of the disease condition most times results in death as 20% - 50% of cases die of complications caused by considerable tissue damage. This has financial, emotional, and social implications for both the family and the public at large. Managing the condition was expensive, due to its severe nature, especially as the persons most affected are of low social economic status [<xref ref-type="bibr" rid="scirp.122034-ref16">16</xref>] . Studies done in Congo show that most of the established cases were males, who had journeyed from the country of Angola where they have been infested and most were men [<xref ref-type="bibr" rid="scirp.122034-ref17">17</xref>] . Another study in Uganda also in agreement revealed that males were more affected, and they had a greater attack rate than females. The age range of the probable case patients was 3 - 64 (median: 32) years. Of all age groups, persons aged 30 - 39 years had the utmost attack rate. (19) The case fatality rate was 33%. The case fatality rate among males was 36% while for females was 22%. The age group of 20 - 30 years had the highest case fatality rate of 36% [<xref ref-type="bibr" rid="scirp.122034-ref17">17</xref>] . In their occupation, more than half (64%) of the cases were farmers; other occupations represented in case-persons included sand miners (5%), wood colliers (5%), small shop owners (3%), teachers (2%), and casual labor (3%). Of note, all case persons were involved in farming events to at least some extent, and the recent outbreak of yellow fever in Nigeria specifically in some communities in Delta State was observed to have affected a certain age range (14 - 35 years) and sex was more affected [<xref ref-type="bibr" rid="scirp.122034-ref17">17</xref>] . Due to the severity of this aliment, it is important to investigate the socio-demographic determinant of these patients to put in place targeted strategies to prevent outbreaks and disease burdens.</p></sec><sec id="s2"><title>3. Statement of Problem</title><p>The yellow fever outbreak is a serious condition of public health concern. The severity of the disease condition most times results in death as 20% - 50% of cases die of complications caused by considerable tissue damage. This has so much effect on both the family and the public at large. Managing the condition is costly especially as the persons most affected are of low social economic status. Of concern is the severe nature of the condition. Therefore, it is imperative to assess the socio-demographic determinant of these patients to initiate early intervention to curb this malady.</p></sec><sec id="s3"><title>4. Significance of the Study</title><p>Understanding the socio-demographic determinant of yellow fever patients will necessitate the need for the government and healthcare facilities to embark on massive sensitization and health education of the masses on yellow fever mostly in endemic communities. Furthermore, this study will help target the people who are usually affected as a result of their occupation and also after a better understanding of the need for early immunization and vaccination against yellow fever disease. There is a paucity of data on yellow fever studies in our environment. Findings from this study will contribute to the body of knowledge on yellow fever. The study can also help policymakers to make policies that will reduce overcrowding. Most of these patients were managed in the isolation center of Federal Medical Center Asaba. This study is aimed at assessing the socio-demographic determining factor of these patients, which will help the government and healthcare facilities to organize Health promotions geared at curbing the disease condition such as immunization of all age groups, especially those within the affected age range.</p></sec><sec id="s4"><title>5. Objectives</title><p>To examine the socio-demographic determinant of patients the yellow fever disease using data collected from Isolation Center, Federal Medical Center Asaba.</p></sec><sec id="s5"><title>6. Research Question</title><p>What is the socio-demographic determinant of patients with yellow fever in Federal Medical Center Asaba?</p></sec><sec id="s6"><title>7. Hypothesis</title><p>There is no significant relationship between patients’ genders and yellow Fever in Federal Medical Center Asaba.</p><p>There is a significant association between gender and yellow Fever in Federal Medical Center Asaba.</p></sec><sec id="s7"><title>8. Material and Methods</title><sec id="s7_1"><title>8.1. Research Design</title><p>This study is a retrospective observational study. The duration of one month was used to collect data from the case note of patients managed for yellow fever.</p></sec><sec id="s7_2"><title>8.2. Research Setting</title><p>The research was conducted at the Centre for Communication Diseases Control and Research (CCDCR) from 28 August to September 2021 in Federal Medical Centre, Asaba, Delta State, Nigeria, as a single-center study, which is one of the three COVID-19 treatment center located in Delta State. The treatment center is completely upheld by the management of Federal Medical Center, Asaba in partnership with the Delta State government. The center has a laboratory and groups of qualified clinical staff who are trained and competent in the management of patients with communicable diseases.</p></sec><sec id="s7_3"><title>8.3. Target Population</title><p>This was made up of established cases of yellow fever who were hospitalized and managed in the isolation unit (CCDCRC) of Federal Medical Center Asaba.</p><sec id="s7_3_1"><title>8.3.1. Inclusion Criteria</title><p>Those that were diagnosed with yellow fever were admitted and managed in the isolation ward (CCDCR) in 2020.</p></sec><sec id="s7_3_2"><title>8.3.2. Exclusion Criteria</title><p>Those that were diagnosed and managed with yellow fever before or after 2020.</p></sec></sec><sec id="s7_4"><title>8.4. Sampling Technique</title><p>The folders of all individuals diagnosed with yellow fever and managed in isolation (CCDRC) in the year 2020 were used.</p></sec><sec id="s7_5"><title>8.5. Sample Size</title><p>All the yellow fever cases that were seen in the isolation center in 2020.</p><sec id="s7_5_1"><title>8.5.1. Study Period</title><p>The study period was from 27<sup>th</sup> August—24<sup>th</sup> September 2021 (one month).</p></sec><sec id="s7_5_2"><title>8.5.2. Ethical Approval</title><p>Ethical approval was sought and gotten from the ethical committee of Federal Medical Center Asaba.</p></sec></sec><sec id="s7_6"><title>8.6. Confidentiality</title><p>The patient case note was treated in such a way as to avoid information contained therein leaking out to the public.</p></sec><sec id="s7_7"><title>8.7. Method of Data Collection</title><p>Relevant information on patients’ socio-demographics was gotten from their case notes.</p></sec><sec id="s7_8"><title>8.8. Method of Data Collection and Analysis</title><p>Data from patients’ case notes were screened for completeness by the researcher and entered and analyzed using Statistical Package for Social Sciences (SPSS V.25). With a P value set at 5% significant, a chi-square was done with the help of a statistician quantitative variables, etc. Descriptive data were presented using frequency tables and charts.</p></sec></sec><sec id="s8"><title>9. Results</title><p><xref ref-type="table" rid="table1">Table 1</xref> shows that 48 (84.2%) were male, and 9 (15.8%) were female. Based on age group, 22 (38.6%) were from &lt;20 years, 28 (49.1%) were from 20 - 39, 5 (8.8%) were from 40 - 59, 2 (3.5%) were above 60 years. 52 (91.2%) were &lt;40 years while 4 (7%) were &gt;40 years. On tribe, 36 (63.2%) were Igbo, 1 (1.8%) were Hausa, 19 (33.3%) were Ika and 1 (1.8%) were TV. On religion, 56 (98.2%) were Christians while 1 (1.8%) were African religion. On marital Status, 40 (70.2%) were single, 3 (5.3%) were cohabiting, 13 (22.8%) were married, and 1 (1.8%) were separated or divorced. Based on educational status, 16 (28.1%) attended the primary level of education, 21 (36.8%) attended the secondary level of education, 7 (12.3%) attended the tertiary level of education, 1 (1.8%) had nursery education, 12 (21.1%) had no formal education. In total, while 52 (91.2%) were poorly educated, 5 (8.8%) had tertiary education.</p><p><xref ref-type="fig" rid="fig1">Figure 1</xref> shows that 18 (31.6%) were cured, 37 (64.9%) died, 1 (1.8%) were transferred out, and 1 (1.8%) defaulted.</p><p><xref ref-type="table" rid="table2">Table 2</xref> shows that 56 (98.2%) were domiciled in the delta state while 1 (1.8%) were domiciled in Anambra state. Also, 51 (89.5%) were from rural</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic data of respondents</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency n = 57</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Gender</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >84.2</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >15.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Age group</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;20</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >38.6</td></tr><tr><td align="center" valign="middle" >20 - 39</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >49.1</td></tr><tr><td align="center" valign="middle" >40 - 59</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8.8</td></tr><tr><td align="center" valign="middle" >60+</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >&lt;40</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >91.2</td></tr><tr><td align="center" valign="middle" >&gt;40</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >missing value</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Tribe</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Igbo</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >63.2</td></tr><tr><td align="center" valign="middle" >Hausa</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Ika</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle" >TV</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Religion</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Christianity</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >98.2</td></tr><tr><td align="center" valign="middle" >Islam</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >African religion</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Marital Status</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >70.2</td></tr><tr><td align="center" valign="middle" >Co-habiting</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5.3</td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >22.8</td></tr><tr><td align="center" valign="middle" >Separated/Divorces</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Educational Status</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Nursery</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Primary</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >28.1</td></tr><tr><td align="center" valign="middle" >Secondary</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >36.8</td></tr><tr><td align="center" valign="middle" >Tertiary</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >12.3</td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >21.1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Residential status of yellow fever patients managed at CCDCR, FMC Asaba</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency n = 57</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >State of domicile</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Delta</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >98.2</td></tr><tr><td align="center" valign="middle" >Anambra</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Area of domicile</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Rural</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >89.5</td></tr><tr><td align="center" valign="middle" >Urban</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >10.5</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Place of domicile</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Nsukwa</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle" >Agbor</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >45.6</td></tr><tr><td align="center" valign="middle" >Ogbe eku</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >12.3</td></tr><tr><td align="center" valign="middle" >Iwa-oyibo</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >Umutu kwale</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >5.2</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><p>areas and 6 (10.5%) were from urban areas. Based on the place of domicile, 19 (33.3%) were from Nsukka, 26 (45.6%) were from Agbor, 7 (12.3%) were from Ogbe eku, 2 (3.5%) were from Iwa-oyibo, and 3 (5.2%) were from out kwale.</p><p><xref ref-type="table" rid="table3">Table 3</xref> reveals that 38 (66.7%) stayed in the hospital for &lt;1 week, 11 (19.3%) remained in the hospital for &gt;1 week &lt;2 weeks, 7 (12.3%) stayed in the hospital for &gt;2 weeks &lt;1 month, and 1 (1.8%) stayed in the hospital for &gt;1 month.</p><p><xref ref-type="table" rid="table4">Table 4</xref> shows that 18 (31.6%) take alcohol, 8 (14%) smoke, and 2 (3.5%) have a sedentary lifestyle.</p><p>From <xref ref-type="fig" rid="fig2">Figure 2</xref> it shows that the majority of yellow fever patients presented with fever 55 (96.5%), followed by jaundice 50 (87.7%) and so on; those who presented consciously were 42 (73.7%) were conscious at presentation and 15 (26.3%) were not. 15 (26.3%) were unconscious at the presentation while 42 (73.7%) were not. 50 (87.7%) had jaundice and 7 (12.3%) were not. 23 (40.4%) had convulsions while 34 (59.6%) did not. 55 (96.5%) had a fever and 2 (3.5%) did not. 33 (57.9%) were bleeding and 24 (42.1%) were not bleeding. 5 (8.8%)</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Length of stay of yellow fever patient managed at CCDCR, FMC Asaba</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency n = 57</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >&lt;1 week</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >66.7</td></tr><tr><td align="center" valign="middle" >&gt;1 week &lt;2 weeks</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >19.3</td></tr><tr><td align="center" valign="middle" >&gt;2 weeks &lt;1 month</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >12.3</td></tr><tr><td align="center" valign="middle" >&gt;1 month</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Social life status of yellow fever patient managed at CCDCR, FMC Asaba</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Present</th><th align="center" valign="middle" >Percentage (%)</th><th align="center" valign="middle" >Absent</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Alcohol consumption</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >31.6</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >Smoking</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >8.8</td></tr><tr><td align="center" valign="middle" >Sedentary lifestyle</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.5</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >12.3</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Bleeding sites outcome of yellow fever patients managed at CCDCR, FMC Asaba</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency n = 57</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Nose</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >Eyes</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >10.5</td></tr><tr><td align="center" valign="middle" >All orifice</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >24.6</td></tr><tr><td align="center" valign="middle" >Mouth</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >26.3</td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >35.1</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Rashes sites outcome of yellow fever patients managed at CCDCR, FMC Asaba</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >Frequency n = 57</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Face</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.8</td></tr><tr><td align="center" valign="middle" >Trunk</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >All over the body</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.5</td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >87.7</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table7" ><label><xref ref-type="table" rid="table7">Table 7</xref></label><caption><title> Association between Yellow fever and gender (Chi-square of a single variable*Gender)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >YF patients</th><th align="center" valign="middle" >P value/chi-sq</th></tr></thead><tr><td align="center" valign="middle" >MALE</td><td align="center" valign="middle" >48 (84.2%)</td><td align="center" valign="middle" >X<sup>2</sup> = 26.6</td></tr><tr><td align="center" valign="middle" >FEMALE</td><td align="center" valign="middle" >9 (15.78%)</td><td align="center" valign="middle" >P = 0.00</td></tr><tr><td align="center" valign="middle" >TOTAL</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>had rashes and 52 (91.2%) did not. Based on other presentations, 7 (12.3%) presented with vomiting, 14 (24.6%) presented with diarrhea, 16 (28.1%) presented with abdominal pains and 20 (35.1%) had other presentations.</p><p><xref ref-type="table" rid="table5">Table 5</xref> shows that 2 (3.5%) were bleeding from the nose, 6 (10.5%) were bleeding from the eyes, 14 (24.6%) were bleeding from all orifices, 15 (26.3%) were bleeding from the mouth, 20 (35.1%) were not bleeding.</p><p><xref ref-type="table" rid="table6">Table 6</xref> illustrates that 1 (1.8%) had rashes on the face, 4 (7%) had rashes on the trunk, 2 (3.5%) had rashes all over the body, 50 (87.7%) had no rash.</p><p>There is a significant association between Yellow fever and gender, X<sup>2</sup>=26.6, p value= 0.00, <xref ref-type="table" rid="table7">Table 7</xref>.</p></sec><sec id="s9"><title>10. Discussion</title><p>This study on the socio-demographic determinant of Yellow fever of patients managed in CCDRC showed that most of them (49.1%) were between ages 20 - 39 followed by ages less than 20 (38.6%); this could be that men in that age range are strong and engages in such activities as farming, hunting, and fishing in areas where they could be infected. Men were more (84.2%) than women (15.8%), buttressing the fact that men are more exposed to YF because they are more engaged in agricultural activities, which agrees with the study in Uganda and Angola. The majority of confirmed cases were in males aged 15 - 19; in the same vein a chi-square test of a single variable to test the hypothesis showed that gender was statistically relevant with x<sup>2</sup> 26.6 and p value 0.00, showing that an association exists between gender and YF transmission probably due to above-mentioned reasons. On educational status, the majority of the patients (36.8%) had secondary education, but then 21.1% had no formal education. Most of the individuals affected were single 40 (70.2%), and the numbers of married affected were 13 (22.8%). The majority of the affected individuals were Igbo 36 (63.2%), and ika 19 (33.3%) were of the minority. Almost all the patients were from Delta state 56 (98.2%), mainly from rural areas 51 (89.5%) in which most of them reside in Nsukwa 19 (33.3%) and agbor (45.6%). The major occupation of residents in this area is farming and hunting where young people below the age of 40 years go to the forest and jungle area. Where they encounter the vector (mosquitoes Aedes) constituting the jungle cycle of transmission (24), where there may be transmission from monkeys and small mammals by mosquitoes Aedes Africans.</p><p>However, the findings of the research also revealed that the length of hospital stay of the patients was less than one week to greater than one month whereby the majority of the patients 38 (66.7%) stayed in the hospital less than a week. This is directly related to the severity of the presentation. The case fatality rate for hospitalized patients was approximately 40% (5) which is high. This agrees with our study that a majority of 37 (64.9%) and 18 (31.6%) were managed and recovered. The clinical findings revealed that most of the patients 42 (73.7%) presented as conscious, with 55 (96.5%) presenting with fever, followed by jaundice 50 (87.7%) then bleeding 33 (53.9%) mostly from all orifices followed by convulsion 23 (40.4%) then rashes 5 (8.8%). This study agrees with the study done in Brazil by Surly Hiromi, which shows that 234 (94.4%) presented with fever and 150 (69.1%) presented with jaundice. However, the limitation of this study is the fact that the sample size of patients managed with YF is small, however, one case of Yellow fever is reportable and requires immediate action from public health leadership and authority.</p></sec><sec id="s10"><title>11. Recommendation</title><p>This study recommends broad sensitization of the general public most especially, the affected areas on the cause, mode of transmission, sign, and symptoms, and prevention of yellow fever. Educating the public will raise the sense of awareness which will lead to early presentation to the health care facilities. In addition, routine vaccination campaigns should be elaborated by the health care workers such that a greater proportion of the affected community can be immunized. Lastly, genome sequencing research should be carried out on affected persons to know if there is a cellular reason for males being more affected than women.</p></sec><sec id="s11"><title>12. Conclusions</title><p>Socio-demographic factors play a great role in the prevention and control of yellow fever outbreaks. Population or areas of an outbreak should be given high priority in health promotion and sensitization, so therefore, people in the rural community, especially in the agricultural industry like farmers, hunters, fishermen, and palm wine tappers should be targeted for those promotion/as they are at high risk of transmission; also vaccination must be given high priority and in case of vaccine unavailability, research has shown that as little as 0.5 mls can prevent from YF. Personal protective garments should be given to those who work in the forest and jungle. In other to minimize the outbreak, there is a need for wider coverage of immunization and sensitization of the public on the route of transmission, signs, and symptoms of the disease condition. These will help to curb the spread, reduce the severity and minimize the outbreak of the disease condition.</p><p>In addition, the breading site of the vector (aedes aegypti), usually the forest where hunting and farming take play, needs to be destroyed or fumigated. Environmental sanitation will go a long way to reduce community spread.</p></sec><sec id="s12"><title>Acknowledgements</title><p>The authors wish to acknowledge the State government for building a Centre for Communicable disease and Research and Control in Federal Medical Centre and others who contributed in one way or the other.</p></sec><sec id="s13"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s14"><title>Cite this paper</title><p>Ezunu, N.E., Egeonu, J.I., Osihro, A.H., Onyemushani, U.-O., Said, A., Oyakhire, O.C., Wayemeru, O.E., Okey-Ezufo, C.O., Eze-Otulaka, C., Inegbejie, F., Oghale, C.A., Ofomata, D.C., Onubogu, G.N., Okpomo, O.P., Okorhi, E.U., Agbele, O.T., Ojimba, A.O., Aigbokhaode, A.Q., Ugoeze, F.C., Osiatuma, V.A., Ezunu, E.O., Jisieike, O.N. and Omoyibo, E.E. (2022) Socio-Demographic Determinant of Yellow Fever Patient: A Retrospective Study (2020), Federal Medical Center, Asaba. Journal of Biosciences and Medicines, 10, 225-238. https://doi.org/10.4236/jbm.2022.1012018</p></sec></body><back><ref-list><title>References</title><ref id="scirp.122034-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Mutebi, J.-P. and Barrett, A.D. (2002) The Epidemiology of Yellow Fever in Africa. Microbes and Infection, 4, 1459-1468. https://doi.org/10.1016/S1286-4579(02)00028-X</mixed-citation></ref><ref id="scirp.122034-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2018) Eliminate Yellow Fever Epidemics (EYE): Strategy. WHO, Geneva. https://www.who.int/&gt;initiatives</mixed-citation></ref><ref id="scirp.122034-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Jentes, E.S., Poumerol, G., Gershman, M.D., et al. (2011) The Revised Global Yellow Fever Risk Map and Recommendations for Vaccination, 2010: Consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. The Lancet Infectious Diseases, 11, 622-632. https://doi.org/10.1016/S1473-3099(11)70147-5</mixed-citation></ref><ref id="scirp.122034-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Carey, D.E., Kemp, G.E., Troup, J.M., et al. (1972) Epidemiological Aspects of the 1969 Yellow Fever Epidemic in Nigeria. Bulletin of the World Health Organization, 46, 645-651.https://europepmc.org/article/p.m.c/2480795</mixed-citation></ref><ref id="scirp.122034-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2017) New Technology Allows for Rapid Diagnosis of Ebola in Democratic Republic of the Congo. WHO, Geneva.https://afro.who.int/news/new/june/2017</mixed-citation></ref><ref id="scirp.122034-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2019) Yellow Fever. WHO, Geneva.http://www.who.int/</mixed-citation></ref><ref id="scirp.122034-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Monath, T.P. (2001) Yellow Fever: An Update. The Lancet Infectious Diseases, 1, 11-20. https://doi.org/10.1016/S1473-3099(01)00016-0</mixed-citation></ref><ref id="scirp.122034-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Woodall, J.P. and Yuill, T.M. (2016) Why Is the Yellow Fever Outbreak in Angola a ‘Threat to the Entire World’? International Journal of Infectious Diseases, 48, 96-97. https://doi.org/10.1016/j.ijid.2016.05.001</mixed-citation></ref><ref id="scirp.122034-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Barrett, A.D.T. (2017) Yellow Fever Lives Attenuated Vaccine: A Very Successful Live Attenuated Vaccine but Still We Have Problems Controlling the Disease. Vaccine, 35, 5951-5955. https://doi.org/10.1016/j.vaccine.2017.03.032</mixed-citation></ref><ref id="scirp.122034-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Monath, T.P. and Vasconcelos, P.F.C. (2015) Yellow Fever. Journal of Clinical Virology, 64, 160-173. https://doi.org/10.1016/j.jcv.2014.08.030</mixed-citation></ref><ref id="scirp.122034-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2015) Emergencies Preparedness, Response—Yellow Fever in the Democratic Republic of the Congo. WHO, Geneva. https://www.who.int/</mixed-citation></ref><ref id="scirp.122034-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Baba, M.M. and Ikusemoran, M. (2017) Is the Absence or Intermittent YF Vaccination the Major Contributor to Its Persistent Outbreaks in Eastern Africa? Biochemical and Biophysical Research Communications, 492, 548-557. https://doi.org/10.1016/j.bbrc.2017.01.079</mixed-citation></ref><ref id="scirp.122034-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2011) Yellow Fever Risk Mapping: Background for the Consultation on Yellow Fever and International Travel, 2010. WHO, Geneva.</mixed-citation></ref><ref id="scirp.122034-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Monath, T.P. (2008) Treatment of Yellow Fever. Antiviral Research, 78, 116-124.https://doi.org/10.1016/j.antiviral.2007.10.009</mixed-citation></ref><ref id="scirp.122034-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Ho, Y.-L., Joelsons, D., Leite, G.F.C., et al. (2019) Severe Yellow Fever in Brazil: Clinical Characteristics and Management. Journal of Travel Medicine, 26, Article ID: taz040. https://doi.org/10.1093/jtm/taz040</mixed-citation></ref><ref id="scirp.122034-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Ingelbeen, B., Weregemere, N.A., Noel, H., Tshapenda, G.P., Mossoko, M., Nsio, J., et al. (2018) Urban Yellow Fever Outbreak-Democratic Republic of Congo, 2016: Towards More Rapid Case Detection. PLOS Neglected Tropical Diseases, 12, e0007029. https://doi.org/10.1371/journal.pntd.0007029</mixed-citation></ref><ref id="scirp.122034-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Kwagonza, L., Masiira, B., Kyobe-Bosa, H., et al. (2018) Outbreak of Yellow Fever in Central and Southern Western Uganda from February-May 2016. BMC Infectious Diseases, 18, Article No. 548. https://doi.org/10.1186/s12879-018-3440-y</mixed-citation></ref></ref-list></back></article>